| Literature DB >> 27083876 |
Ireneusz Całkosiński1, Jacek Majda2, Grzegorz Terlecki3, Kinga Gostomska-Pampuch4, Katarzyna Małolepsza-Jarmołowska5, Sylwia Sobolewska6, Aleksandra Całkosińska1, Aleksandra Kumala1, Andrzej Gamian3,7.
Abstract
A significant role is played in inflammation by the liver, which, stimulated by inflammatory mediators, synthetizes plasma proteins with various dynamics. The purpose of these studies is to generate a detailed dynamic analysis of changes to concentrations of plasma and serum protein fractions and selected acute-phase proteins as well as nonspecific biochemical indices during the course of an induced pleurisy. The studies were conducted on female inbred Buffalo rats, which were divided into two groups: a control group (C) and an experimental group (IP) in which pleurisy was induced. In the IP group, significant changes in biochemical indices were observed between the 48th and 96th hours of pleurisy. A reduction of albumin, transferrin, urea, and creatinine concentrations was observed, while concentrations of the complement components C3 and C4, haptoglobin, and fibrinogen increased. An early increase of IL-1 was observed, while increases of IL-6 and TNF were noted in the later period. The maximum intensity of the processes described above occurred between the 72nd and 96th hours of pleurisy.Entities:
Keywords: acute-phase proteins; electrophoresis of serum proteins; inflammatory reaction; pleurisy
Mesh:
Substances:
Year: 2016 PMID: 27083876 PMCID: PMC4883275 DOI: 10.1007/s10753-016-0339-x
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092
Fig. 1Electrophoresis of rat serum proteins in own study (I) [7] and by Weimer (II) [32]: Ia control, Ib carrageenan-induced inflammation (72 h); IIa control, IIb turpentine-induced inflammation.
Electrophoretic Separation of Rat Serum in the Course of Experimental Pleurisy
| Albumin (g/dl) | Albumin (%) | Globulin | Total protein (g/dl) | Albumin/globulin | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| α1 (g/dl) | α1 (%) | α2 (g/dl) | α2 (%) | β (g/dl) | β (%) | γ (g/dl) | γ (%) | ||||||
| C |
| 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
|
| 3.84 | 66.16 | 0.374 | 6.5 | 0.303 | 5.24 | 0.896 | 15.38 | 0.391 | 6.72 | 5.81 | 2.01 | |
| SD | 0.48 | 5.06 | 0.14 | 2.58 | 0.106 | 1.92 | 0.181 | 2.31 | 0.122 | 1.93 | 0.54 | 0.42 | |
| IP (24 h) |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
|
| 3.04 | 52.1 | 0.924 | 15.78 | 0.506 | 8.66 | 1.042 | 17.84 | 0.334 | 5.66 | 5.85 | 1.09 | |
| SD | 0.11 | 3.03 | 0.123 | 1.45 | 0.027 | 0.47 | 0.121 | 1.56 | 0.094 | 1.43 | 0.28 | 0.13 | |
|
| 0.001*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0003*** | 0.001*** | 0.104 | 0.035 | 0.343 | 0.267 | 0.875 | 0.0000*** | |
| IP (48 h) |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
|
| 3.11 | 55.24 | 0.776 | 13.84 | 0.526 | 9.38 | 0.936 | 16.58 | 0.282 | 5.02 | 5.62 | 1.24 | |
| SD | 0.38 | 1.71 | 0.053 | 1.03 | 0.051 | 0.9 | 1.14 | 1.28 | 0.039 | 0.61 | 0.58 | 0.09 | |
|
| 0.005** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0001*** | 0.0000*** | 0.652 | 0.277 | 0.064 | 0.069 | 0.512 | 0.0000*** | |
| IP (72 h) |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
|
| 2.99 | 51.32 | 1.108 | 19 | 0.462 | 7.86 | 1.048 | 17.98 | 0.226 | 3.86 | 5.83 | 1.05 | |
| SD | 0.09 | 1.72 | 0.021 | 0.41 | 0.085 | 1.43 | 0.051 | 0.85 | 0.065 | 1.05 | 0.11 | 0.07 | |
|
| 0.0008*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.005** | 0.009** | 0.081 | 0.022* | 0.008* | 0.004** | 0.923 | 0.0000*** | |
| IP (96 h) |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
|
| 3.83 | 64.02 | 0.492 | 8.26 | 0.476 | 7.94 | 0.9 | 14.92 | 0.294 | 4.86 | 5.99 | 1.78 | |
| SD | 0.11 | 1.65 | 0.126 | 2.28 | 0.018 | 0.24 | 0.187 | 2.48 | 0.084 | 1.22 | 0.24 | 0.13 | |
|
| 0.96 | 0.367 | 0.101 | 0.177 | 0.002** | 0.005** | 0.965 | 0.701 | 0.109 | 0.054 | 0.468 | 0.243 | |
| IP (120 h) |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
|
| 3.48 | 57.28 | 0.722 | 11.92 | 0.582 | 9.54 | 0.95 | 15.6 | 0.344 | 5.62 | 6 | 1.25 | |
| SD | 0.17 | 2.22 | 0.09 | 1.76 | 0.054 | 0.57 | 0.094 | 1.36 | 0.109 | 1.58 | 0.25 | 0.17 | |
|
| 0.112 | 0.0000*** | 0.0000*** | 0.0002*** | 0.0000*** | 0.0000*** | 0.531 | 0.838 | 0.441 | 0.255 | 0.441 | 0.001*** | |
| IP (144 h) |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
|
| 3.8 | 61.04 | 0.652 | 10.48 | 0.454 | 7.32 | 1.052 | 16.92 | 0.27 | 4.28 | 6.23 | 1.57 | |
| SD | 0.21 | 2.35 | 0.115 | 2.03 | 0.085 | 1.51 | 0.127 | 1.84 | 0.094 | 1.47 | 0.17 | 0.16 | |
|
| 0.855 | 0.0000*** | 0.0004*** | 0.004** | 0.007** | 0.035 | 0.085 | 0.18 | 0.051 | 0.015* | 0.101 | 0.032* | |
C control group, IP group with induced pleurisy, N number of animals, X arithmetic average, SD standard deviation, T statistical significance relative to control group (0.05 ≥ T > 0.01 − * | 0.01 ≥ T > 0.001 − ** | 0.001 ≥ T − ***)
Fig. 2a Electrophoretic separation of rat serum proteins in induced pleurisy. b Changes of the albumin-to-globulin ratio during induced pleurisy.
Liver Enzymes in the Rat Serum in the Course of Experimental Pleurisy
| AST (U/l) | ALT (U/l) | ||
|---|---|---|---|
| C |
| 10 | 21 |
|
| 172.28 | 42.8 | |
| SD | 40.44 | 7.48 | |
| IP (24 h) |
| 10 | 21 |
|
| 156.22 | 46.28 | |
| SD | 37.57 | 9.24 | |
|
| 0.37 | 0.188 | |
| IP (48 h) |
| 10 | 14 |
|
| 172.32 | 37.65 | |
| SD | 48.99 | 8.46 | |
|
| 0.998 | 0.067 | |
| IP (72 h) |
| 10 | 15 |
|
| 394.44 | 44.71 | |
| SD | 28.59 | 6.59 | |
|
| 0.0000*** | 0.432 |
C control group, IP group with induced pleurisy, AST aspartate aminotransferase, ALT alanine aminotransferase N number of animals, X arithmetic average, SD standard deviation, T statistical significance relative to control group (0.05 ≥ T > 0.01 − * | 0.01 ≥ T > 0.001 − ** | 0.001 ≥ T − ***)
Fig. 3Changes in liver enzyme activities during induced pleurisy. AST aspartate aminotransferase, ALT alanine aminotransferase.
Biochemical Parameters of the Rat Serum and Plasma in the Course of Experimental Pleurisy
| Albumin (g/dl) | TP (g/dl) | TRF (mg/dl) | Haptoglobin (mg/dl) | Complement component | Urea (mg/dl) | Creatinine (mg/dl) | Fibrinogen (g/dl) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| C3 (mg/dl) | C4 (mg/dl) | |||||||||
| C |
| 25 | 25 | 21 | 21 | 20 | 21 | 16 | 13 | 10 |
|
| 5.24 | 6.29 | 106.74 | 4.91 | 1.79 | 8.43 | 44.84 | 0.772 | 1.09 | |
| SD | 0.35 | 0.69 | 10.24 | 2.43 | 0.82 | 2.09 | 6.99 | 0.099 | 0.2 | |
| IP (24 h) |
| 29 | 31 | 24 | 25 | 24 | 24 | 16 | 13 | 7 |
|
| 4.24 | 5.44 | 149.03 | 80.36 | 53.38 | 5.41 | 29.44 | 0.587 | 1.99 | |
| SD | 0.72 | 0.96 | 20.38 | 18.92 | 19.61 | 2.21 | 8.33 | 0.143 | 0.44 | |
|
| 0.0000*** | 0.0005*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0000*** | |
| IP (48 h) |
| 23 | 28 | 23 | 23 | 19 | 23 | 14 | 14 | 11 |
|
| 4.45 | 6.01 | 145.23 | 91.56 | 88.45 | 8.85 | 25.26 | 0.484 | 2.18 | |
| SD | 1.05 | 0.81 | 19.86 | 27.37 | 15.84 | 2.96 | 5.1 | 0.048 | 0.81 | |
|
| 0.0008*** | 0.179 | 0.0000*** | 0.0000*** | 0.0000*** | 0.596 | 0.0000*** | 0.0000*** | 0.0005*** | |
| IP (72 h) |
| 26 | 31 | 26 | 26 | 22 | 24 | 15 | 15 | 6 |
|
| 3.99 | 5.13 | 132.26 | 89.22 | 47.97 | 6 | 32.1 | 0.45 | 1.64 | |
| SD | 1.17 | 1.27 | 20.43 | 18.72 | 8.25 | 2.12 | 8.73 | 0.092 | 0.22 | |
|
| 0.0000*** | 0.0001*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0004 | 0.0000*** | 0.0000*** | 0.0002*** | |
| IP (96 h) |
| 5 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | |
|
| 4.66 | 5.86 | 38.54 | 86.06 | 89.64 | 7.95 | 26.4 | 0.576 | ||
| SD | 0.24 | 0.47 | 1.89 | 9.74 | 8.19 | 1.61 | 3.05 | 0.053 | ||
|
| 0.002** | 0.073 | 0.0000*** | 0.0000*** | 0.0000*** | 0.633 | 0.0000*** | 0.0008*** | ||
| IP (120 h) |
| 5 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 15 |
|
| 4.38 | 5.96 | 32.66 | 62.42 | 73.82 | 10.3 | 26.2 | 0.652 | 1.39 | |
| SD | 0.39 | 0.39 | 4.12 | 6.15 | 11.44 | 1.54 | 3.56 | 0.035 | 0.39 | |
|
| 0.0000*** | 0.156 | 0.0000*** | 0.0000*** | 0.0000*** | 0.074 | 0.0000*** | 0.019* | 0.034* | |
| IP (144 h) |
| 5 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | |
|
| 4.62 | 6.13 | 38.76 | 55.04 | 90.44 | 12.29 | 32.8 | 0.66 | ||
| SD | 0.27 | 0.19 | 0.93 | 14 | 7.23 | 1.24 | 2.95 | 0.029 | ||
|
| 0.0009*** | 0.477 | 0.0000*** | 0.0002*** | 0.0000*** | 0.0007*** | 0.002** | 0.027* | ||
| IP (168 h) |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |
|
| 4.8 | 5.94 | 39.76 | 87.86 | 108.26 | 15.25 | 26.34 | 0.655 | ||
| SD | 0.23 | 0.23 | 0.5 | 0.18 | 1.72 | 0.84 | 2.76 | 0.063 | ||
|
| 0.012* | 0.27 | 0.0000*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.0000*** | 0.027* | ||
C control group, IP group with induced pleurisy, TP total protein, TRF transferrin, N number of animals, X arithmetic average, SD standard deviation, T statistical significance relative to control group (0.05 ≥ T > 0.01 − * | 0.01 ≥ T > 0.001 − ** | 0.001 ≥ T − ***)
Fig. 4a Changes in the concentrations of albumin and total protein in the serum and fibrinogen in the rat plasma in the course of induced pleurisy. Fibr fibrinogen, Alb albumin, Tp total protein. b Changes in concentrations of biochemical parameters in the rat serum during induced pleurisy. TRF transferrin, Hapt haptoglobin, C3 C3 complement protein, C4 C4 complement protein. c Changes in levels of biochemical markers in induced pleurisy. Creat creatinine (concentration × 10−1).
Proinflammatory Cytokines in the Rat Serum in the Course of Experimental Pleurisy
| IL-1 (pg/ml) | IL-6 (pg/ml) | TNF (pg/ml) | ||
|---|---|---|---|---|
| C |
| 9 | 9 | 9 |
|
| 29.12 | 29.23 | 2.9 | |
| SD | 6.73 | 10.58 | 1.09 | |
| IP (24 h) |
| 6 | 7 | 6 |
|
| 74.45 | 32.22 | 21.83 | |
| SD | 26.25 | 5.43 | 2.56 | |
|
| 0.0002*** | 0.509 | 0.0000*** | |
| IP (48 h) |
| 6 | 6 | |
|
| 107.6 | 22.53 | ||
| SD | 22.06 | 2.81 | ||
|
| 0.0000*** | 0.0000*** | ||
| IP (72 h) |
| 6 | 7 | 6 |
|
| 95.62 | 43.47 | 23.57 | |
| SD | 9.91 | 10.33 | 3.21 | |
|
| 0.0000*** | 0.017* | 0.0000*** | |
| IP (96 h) |
| 6 | 6 | |
|
| 101.18 | 22.08 | ||
| SD | 14.87 | 2.59 | ||
|
| 0.0000*** | 0.0000*** | ||
| IP (120 h) |
| 6 | 6 | 6 |
|
| 92.23 | 21.34 | 19.55 | |
| SD | 7.71 | 5.02 | 0.99 | |
|
| 0.0000*** | 0.115 | 0.0000*** | |
| IP (144 h) |
| 6 | 6 | |
|
| 90.6 | 18.52 | ||
| SD | 20 | 1 | ||
|
| 0.0000*** | 0.0000*** |
C control group, IP group with induced pleurisy, IL-1 interleukin-1β, IL-6 interleukin-6, TNF tumor necrosis factor, N number of animals, X arithmetic average, SD standard deviation, T statistical significance relative to control group (0.05 ≥ T > 0.01 − * | 0.01 ≥ T > 0.001 − ** | 0.001 ≥ T − ***)
Fig. 5Changes in the concentrations of proinflammatory cytokines during induced pleurisy. TNF tumor necrosis factor, IL-6 interleukin-6, IL-1 interleukin-1β.